Chemomab Therapeutics Ltd. Increase (Decrease) in Prepaid Expense and Other Assets
Chemomab Therapeutics Ltd. (CMMB) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.14 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-03-23
- Chemomab Therapeutics Ltd. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-06-30 was $3.00K, a 99.73% decline year-over-year.
- Chemomab Therapeutics Ltd. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-03-31 was -$814.00K, a 324.24% decline year-over-year.
- Chemomab Therapeutics Ltd. increase (decrease) in prepaid expense and other assets for the quarter ending 2022-12-31 was -$536.00K.
- Chemomab Therapeutics Ltd. increase (decrease) in prepaid expense and other assets for the quarter ending 2022-09-30 was -$883.00K.
- Chemomab Therapeutics Ltd. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $99.00K.
- Chemomab Therapeutics Ltd. increase (decrease) in prepaid expense and other assets for fiscal 2019 was -$2.31M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.14M 20-F · filed 2026-03-23 | |||||||
| 2025-06-30 | -$684.00K 6-K · filed 2025-08-14 | |||||||
| 2024-12-31 | $487.00K 20-F · filed 2026-03-23 | |||||||
| 2024-06-30 | -$470.00K 6-K · filed 2025-08-14 | |||||||
| 2023-12-31 | -$903.00K 20-F · filed 2026-03-23 | |||||||
| 2023-06-30 | $3.00K derived: 6-K 6 month − 10-Q 3 month · filed 2024-08-21 | -$811.00K 6-K · filed 2024-08-21 | -$1.35M derived: sum of 3 quarters · filed 2025-04-04 | -$2.23M derived: sum of 4 quarters · filed 2025-04-04 | ||||
| 2023-03-31 | -$814.00K 10-Q · filed 2023-05-11 | -$1.35M derived: sum of 2 quarters · filed 2025-04-04 | -$2.23M derived: sum of 3 quarters · filed 2025-04-04 | -$1.11M derived: sum of 4 quarters · filed 2025-04-04 | ||||
| 2022-12-31 | -$536.00K derived: 20-F 12 month − 10-Q 9 month · filed 2025-04-04 | -$1.42M derived: sum of 2 quarters · filed 2025-04-04 | -$299.00K derived: sum of 3 quarters · filed 2025-04-04 | $64.00K 20-F · filed 2025-04-04 | ||||
| 2022-09-30 | -$883.00K derived: 10-Q 9 month − 6-K 6 month · filed 2022-11-10 | $237.00K derived: sum of 2 quarters · filed 2023-08-14 | $600.00K 10-Q · filed 2022-11-10 | $513.00K derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2022-06-30 | $1.12M derived: 6-K 6 month − 10-Q 3 month · filed 2023-08-14 | $1.48M 6-K · filed 2023-08-14 | $1.40M derived: sum of 3 quarters · filed 2024-03-28 | $1.01M derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2022-03-31 | $363.00K 10-Q · filed 2023-05-11 | $276.00K derived: sum of 2 quarters · filed 2024-03-28 | -$108.00K derived: sum of 3 quarters · filed 2024-03-28 | $2.48M derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2021-12-31 | -$87.00K derived: 20-F 12 month − 10-Q 9 month · filed 2024-03-28 | -$471.00K derived: sum of 2 quarters · filed 2024-03-28 | $2.12M derived: sum of 3 quarters · filed 2024-03-28 | $2.06M 20-F · filed 2024-03-28 | ||||
| 2021-09-30 | -$384.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.20M derived: sum of 2 quarters · filed 2022-11-10 | $2.15M 10-Q · filed 2022-11-10 | $2.21M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $2.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.53M 10-Q · filed 2022-08-12 | $2.60M derived: sum of 3 quarters · filed 2022-08-12 | $2.57M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$57.00K 10-Q · filed 2022-05-12 | $10.00K derived: sum of 2 quarters · filed 2022-05-12 | -$19.00K derived: sum of 3 quarters · filed 2022-05-12 | -$10.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $38.00K derived: sum of 2 quarters · filed 2022-03-30 | $47.00K derived: sum of 3 quarters · filed 2022-03-30 | $99.00K 10-K · filed 2022-03-30 | $88.00K 10-K · filed 2021-03-09 | |||
| 2020-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$20.00K derived: sum of 2 quarters · filed 2021-11-12 | $32.00K 10-Q · filed 2021-11-12 | -$16.00K 10-Q · filed 2020-11-16 | $2.55M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $61.00K 10-Q · filed 2021-08-13 | $212.00K 10-Q · filed 2020-08-14 | $2.58M derived: sum of 3 quarters · filed 2021-08-13 | -$416.00K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $52.00K 10-Q · filed 2021-05-13 | -$94.00K 10-Q · filed 2020-05-07 | $2.57M derived: sum of 2 quarters · filed 2021-05-13 | -$425.00K derived: sum of 3 quarters · filed 2021-05-13 | -$755.00K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$477.00K derived: sum of 2 quarters · filed 2021-03-09 | -$807.00K derived: sum of 3 quarters · filed 2021-03-09 | -$2.31M 10-K · filed 2021-03-09 | ||||
| 2019-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$3.33M derived: sum of 2 quarters · filed 2020-11-16 | -$4.82M 10-Q · filed 2020-11-16 | |||||
| 2019-06-30 | -$330.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$1.83M 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | -$1.50M 10-Q · filed 2020-05-07 |